Clinical Outcomes will be attending BioTrinity 2024
Oxford University Innovation's Clinical Outcome team will be attending BioTrinity 2024 conference in London, UK on the 23-24th April 2024.
Clinical Outcomes is a product and service business (within Oxford University Innovation) dedicated to the provision and support of high-quality validated outcomes measures (questionnaires) across the healthcare sector. The vast majority of our measures are Patient Reported Outcome (PRO) Measures (or sometimes referred to as PROMs).
We provide licences for some of the most respected and widely deployed outcome measures used by the pharmaceutical industry, healthcare providers, academia and medical device manufacturers.
The Clinical Outcomes team can also provide expert advice on the development and psychometric validation of new COAs and PROs, as well as the use of our own and other health outcome measures.
Oxford University Innovation's Clinical Outcome team will be attending BioTrinity 2024 conference in London, UK on the 23-24th April 2024.
Oxford University Innovation announces the much-anticipated relaunch of the Oxford Innovation Society (OIS). With an ambitious 12-month programme of events, OIS aims to fortify connections between Oxford’s companies, investors, industry partners and the vibrant Oxford entrepreneurial ecosystem.
OUI’s Diabetes Health Profiles empower those living with diabetes to have a voice in their healthcare.